101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) link:calculationLink link:presentationLink link:definitionLink 106 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 107 - Disclosure - Nature of Business link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - Basis of Presentation and Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Cash, Cash Equivalents and Investments, Available for Sale link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Accrued Expenses and Other Liabilities link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Collaborations link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Loan Payable link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Earnings (Loss) Per Share link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Subsequent Event link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Cash, Cash Equivalents and Investments, Available for Sale (Tables) link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Accrued Expenses and Other Liabilities (Tables) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Stock-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Earnings (Loss) Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Nature of Business - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Fair Value Measurements - Financial Assets Recognized at Fair Value (Detail) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Fair Value Measurements - Schedule of Activity in Preferred Stock Warrant Liability (Detail) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Cash, Cash Equivalents and Investments, Available for Sale - Cash, Cash Equivalents and Investments, Available for Sale (Detail) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Cash, Cash Equivalents and Investments, Available for Sale - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Accrued Expenses and Other Liabilities - Accrued Expenses and Other Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Collaborations - Celgene - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Collaborations - Jazz Pharmaceuticals - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Collaborations - Avanir - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Stock-Based Compensation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense Related to All Stock Based Awards Recognized in Statements of Operations and Comprehensive Income (Loss) (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Stock-Based Compensation - Estimated Weighted-Average Assumptions of Options Granted (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Loan Payable - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Earnings (Loss) Per Share - Computation of Basic and Diluted Earnings (Loss) Per Share (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Earnings (Loss) Per Share - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Earnings (Loss) Per Share - Common Stock Equivalents Excluded from Calculation of Diluted Loss Per Share (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Subsequent Event - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink